Cover Image
Market Research Report
Product code 
1081223

Bioreactors Market Size By Product Type, By Cell, By Molecule, By Usage, By End-use, Industry Analysis, Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030

Published: | Global Market Insights Inc. | 205 Pages | Delivery time: 2-3 business days

Price

Back to Top
Bioreactors Market Size By Product Type, By Cell, By Molecule, By Usage, By End-use, Industry Analysis, Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
Published: May 17, 2022
Global Market Insights Inc.
Content info: 205 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global bioreactors market is expected to gain tremendous momentum over the forecast years between 2022 and 2030. The projected rise in production of therapeutics to address the growing prevalence of chronic illnesses such as cancer, diabetes, cardiovascular diseases, and more, will augment market growth.

The bioreactors market landscape is classified into product type, molecule, cell, end-use, usage, and regional landscape.

Based on product type, the bioreactors industry is divided into reusable, and single-use. Among these, reusable product segment is projected to showcase a CAGR of approximately 11.9% from 2022 to 2030, driven by mass production trends encouraging adoption of reusable bioreactors. As they offer better product safety with minimal damage risk to product, vaccine manufacturers are heavily inclined towards adoption of reusable bioreactors for commercial production, thereby offering lucrative scope for segment growth.

By cell, the overall bioreactors market is fragmented into yeast cells, mammalian cells, bacterial cells, and others. Use of bioreactors for processing mammalian cells is expected to scale up during the forecast period to help the mammalian cells segment showcase a CAGR of more than 13.4% over the analysis timeline.

Extensive use of mammalian cells in the development of therapeutic drugs, proteins, and viral vaccines will boost the segment outlook. Moreover, ability of mammalian cells to amplify culture growth of biologics is likely to gain popularity in near future.

In terms of molecule, the industry is categorized into vaccines, gene therapy, monoclonal antibodies, stem cells, recombinant proteins, and others. In 2021, the bioreactors market earned revenues of around $697 million from recombinant proteins segment owing to the favorable biophysical and structural characteristics of the molecule that allow for large-scale production. Increasing focus on recombinant protein technology for better vaccine development will fuel segment growth.

With respect to usage, the bioreactors market is divided into commercial production, and development, preclinical & clinical. In 2021, developmental, preclinical, and clinical segment accounted for approximately 20.8% of total market share. Presence of an extensive pipeline of therapeutics catering to novel drugs and vaccine development will accelerate adoption of bioreactors to aid developmental, preclinical, and clinical phases.

Based on end-use, global bioreactors industry is sectioned into biopharma manufacturers, contract manufacturing organizations (CMOs), and R&D organizations. Among these, contract manufacturing organizations (CMOs) end-use segment contributed over $1 billion in revenue back in 2021, driven by the surging number of CMOs across the globe.

Cost-effectiveness, lack of technical expertise and a solid infrastructure are some of the key factors estimated to drive demand for CMOs in emerging nations consolidating adoption of bioreactors by the end-use segment.

In regional landscape, the Latin America bioreactors market is slated to grow at a CAGR of around 14.7% through the projected time period on the back of rising number of R&D facilities across the region. Industry players expanding into emerging economies for affordability reasons and establishing new manufacturing units will propel the growth of bioreactors market across the region.

Product Code: 141

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates and working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 LATAM
    • 1.2.5 MEA
  • 1.3 Forecast calculations
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Bioreactors industry 360 degree synopsis, 2017 - 2030 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Product type trends
    • 2.1.3 Cell trends
    • 2.1.4 Molecule trends
    • 2.1.5 Usage trends
    • 2.1.6 End-use trends
    • 2.1.7 Regional trends

Chapter 3 Bioreactors Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017- 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing pharmaceutical and biotechnology industry
      • 3.3.1.2 Technological advancements in bioreactors
      • 3.3.1.3 Growing focus on orphan drug development
      • 3.3.1.4 Rising demand for personalized medicines
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Low capacity of single-use bioreactors
      • 3.3.2.2 Concerns regarding extractables and/or leachable
  • 3.4 Growth potential analysis
    • 3.4.1 By product type
    • 3.4.2 By cell
    • 3.4.3 By molecule
    • 3.4.4 By usage
    • 3.4.5 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Canada
    • 3.6.3 Europe
    • 3.6.4 China
  • 3.7 Technology landscape
    • 3.7.1 Technology overview of single-use bioreactors
      • 3.7.1.1 Wave-induced motion SUB
      • 3.7.1.2 Single-use Bubble Column
      • 3.7.1.3 Stirred SUB
  • 3.8 Porter's analysis
  • 3.9 Competitive landscape, 2021
  • 3.10 PESTEL analysis

Chapter 4 Bioreactors Market, By Product Type

  • 4.1 Key segment trends
  • 4.2 Single-use
    • 4.2.1 Market size, by region, 2017-2030 (USD Million)
  • 4.3 Reusable
    • 4.3.1 Market size, by region, 2017-2030 (USD Million)

Chapter 5 Bioreactors Market, By Cell

  • 5.1 Key segment trends
  • 5.2 Mammalian cells
    • 5.2.1 Market size, by region, 2017-2030 (USD Million)
  • 5.3 Bacterial cells
    • 5.3.1 Market size, by region, 2017-2030 (USD Million)
  • 5.4 Yeast cells
    • 5.4.1 Market size, by region, 2017-2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017-2030 (USD Million)

Chapter 6 Bioreactors Market, By Molecule

  • 6.1 Key segment trends
  • 6.2 Monoclonal antibodies
    • 6.2.1 Market size, by region, 2017-2030 (USD Million)
  • 6.3 Vaccines
    • 6.3.1 Market size, by region, 2017-2030 (USD Million)
  • 6.4 Recombinant proteins
    • 6.4.1 Market size, by region, 2017-2030 (USD Million)
  • 6.5 Stem cells
    • 6.5.1 Market size, by region, 2017-2030 (USD Million)
  • 6.6 Gene therapy
    • 6.6.1 Market size, by region, 2017-2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Market size, by region, 2017-2030 (USD Million)

Chapter 7 Bioreactors Market, By Usage

  • 7.1 Key segment trends
  • 7.2 Developmental, pre-clinical & clinical
    • 7.2.1 Market size, by region, 2017-2030 (USD Million)
  • 7.3 Commercial production
    • 7.3.1 Market size, by region, 2017-2030 (USD Million)

Chapter 8 Bioreactors Market, By End-use

  • 8.1 Key segment trends
  • 8.2 R&D organizations
    • 8.2.1 Market size, by region, 2017-2030 (USD Million)
  • 8.3 Biopharmaceutical manufacturers
    • 8.3.1 Market size, by region, 2017-2030 (USD Million)
  • 8.4 Contract manufacturing organizations (CMO)
    • 8.4.1 Market size, by region, 2017-2030 (USD Million)

Chapter 9 Bioreactors Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 Market size, by country, 2017-2030 (USD Million)
    • 9.2.2 Market size, by product type, 2017-2030 (USD Million)
    • 9.2.3 Market size, by cell, 2017-2030 (USD Million)
    • 9.2.4 Market size, by molecule, 2017-2030 (USD Million)
    • 9.2.5 Market size, by usage, 2017-2030 (USD Million)
    • 9.2.6 Market size, by end-use, 2017-2030 (USD Million)
    • 9.2.7 U.S.
      • 9.2.7.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.2.7.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.2.7.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.2.7.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.2.7.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.2.8 Canada
      • 9.2.8.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.2.8.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.2.8.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.2.8.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.2.8.5 Market size, by end-use, 2017-2030 (USD million)
  • 9.3 Europe
    • 9.3.1 Market size, by country, 2017-2030 (USD Million)
    • 9.3.2 Market size, by product type, 2017-2030 (USD Million)
    • 9.3.3 Market size, by cell, 2017-2030 (USD Million)
    • 9.3.4 Market size, by molecule, 2017-2030 (USD Million)
    • 9.3.5 Market size, by usage, 2017-2030 (USD Million)
    • 9.3.6 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.7 Germany
      • 9.3.7.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.7.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.7.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.7.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.7.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.8 UK
      • 9.3.8.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.8.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.8.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.8.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.8.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.9 Spain
      • 9.3.9.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.9.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.9.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.9.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.9.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.10 Italy
      • 9.3.10.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.10.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.10.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.10.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.10.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.11 France
      • 9.3.11.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.11.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.11.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.11.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.11.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.12 Netherlands
      • 9.3.12.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.12.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.12.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.12.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.12.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.3.13 Denmark
      • 9.3.13.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.3.13.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.3.13.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.3.13.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.3.13.5 Market size, by end-use, 2017-2030 (USD million)
  • 9.4 Asia Pacific
    • 9.4.1 Market size, by country, 2017-2030 (USD Million)
    • 9.4.2 Market size, by product type, 2017-2030 (USD Million)
    • 9.4.3 Market size, by cell, 2017-2030 (USD Million)
    • 9.4.4 Market size, by molecule, 2017-2030 (USD Million)
    • 9.4.5 Market size, by usage, 2017-2030 (USD Million)
    • 9.4.6 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.7 Japan
      • 9.4.7.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.7.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.7.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.7.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.7.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.8 China
      • 9.4.8.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.8.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.8.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.8.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.8.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.9 India
      • 9.4.9.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.9.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.9.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.9.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.9.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.10 Australia
      • 9.4.10.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.10.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.10.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.10.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.10.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.11 South Korea
      • 9.4.11.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.11.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.11.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.11.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.11.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.4.12 Singapore
      • 9.4.12.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.4.12.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.4.12.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.4.12.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.4.12.5 Market size, by end-use, 2017-2030 (USD million)
  • 9.5 Latin America
    • 9.5.1 Market size, by country, 2017-2030 (USD Million)
    • 9.5.2 Market size, by product type, 2017-2030 (USD Million)
    • 9.5.3 Market size, by cell, 2017-2030 (USD Million)
    • 9.5.4 Market size, by molecule, 2017-2030 (USD Million)
    • 9.5.5 Market size, by usage, 2017-2030 (USD Million)
    • 9.5.6 Market size, by end-use, 2017-2030 (USD million)
    • 9.5.7 Brazil
      • 9.5.7.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.5.7.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.5.7.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.5.7.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.5.7.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.5.8 Mexico
      • 9.5.8.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.5.8.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.5.8.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.5.8.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.5.8.5 Market size, by end-use, 2017-2030 (USD million)
  • 9.6 MEA
    • 9.6.1 Market size, by country, 2017-2030 (USD Million)
    • 9.6.2 Market size, by product type, 2017-2030 (USD Million)
    • 9.6.3 Market size, by cell, 2017-2030 (USD Million)
    • 9.6.4 Market size, by molecule, 2017-2030 (USD Million)
    • 9.6.5 Market size, by usage, 2017-2030 (USD Million)
    • 9.6.6 Market size, by end-use, 2017-2030 (USD million)
    • 9.6.7 South Africa
      • 9.6.7.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.6.7.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.6.7.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.6.7.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.6.7.5 Market size, by end-use, 2017-2030 (USD million)
    • 9.6.8 UAE
      • 9.6.8.1 Market size, by product type, 2017-2030 (USD Million)
      • 9.6.8.2 Market size, by cell, 2017-2030 (USD Million)
      • 9.6.8.3 Market size, by molecule, 2017-2030 (USD Million)
      • 9.6.8.4 Market size, by usage, 2017-2030 (USD Million)
      • 9.6.8.5 Market size, by end-use, 2017-2030 (USD million)

Chapter 10 Company Profiles

  • 10.1 Competitive dashboard, 2021
  • 10.2 Applikon Biotechnology, Inc. (Getinge)
    • 10.2.1 Business overview
    • 10.2.2 Financial data
    • 10.2.3 Product landscape
    • 10.2.4 Strategic outlook
    • 10.2.5 SWOT analysis
  • 10.3 Bbi Biotech
    • 10.3.1 Business overview
    • 10.3.2 Financial data
    • 10.3.3 Product landscape
    • 10.3.4 Strategic outlook
    • 10.3.5 SWOT analysis
  • 10.4 Cellexus Ltd
    • 10.4.1 Business overview
    • 10.4.2 Financial data
    • 10.4.3 Product landscape
    • 10.4.4 Strategic outlook
    • 10.4.5 SWOT analysis
  • 10.5 CerCell ApS
    • 10.5.1 Business overview
    • 10.5.2 Financial data
    • 10.5.3 Product landscape
    • 10.5.4 Strategic outlook
    • 10.5.5 SWOT analysis
  • 10.6 CESCO Bioengineering Co. Ltd.
    • 10.6.1 Business overview
    • 10.6.2 Financial data
    • 10.6.3 Product landscape
    • 10.6.4 Strategic outlook
    • 10.6.5 SWOT analysis
  • 10.7 Eppendorf AG
    • 10.7.1 Business overview
    • 10.7.2 Financial data
    • 10.7.3 Product landscape
    • 10.7.4 Strategic outlook
    • 10.7.5 SWOT analysis
  • 10.8 GEA Group Aktiengesellschaft
    • 10.8.1 Business overview
    • 10.8.2 Financial data
    • 10.8.3 Product landscape
    • 10.8.4 Strategic outlook
    • 10.8.5 SWOT analysis
  • 10.9 Merck Group
    • 10.9.1 Business overview
    • 10.9.2 Financial data
    • 10.9.3 Product landscape
    • 10.9.4 Strategic outlook
    • 10.9.5 SWOT analysis
  • 10.10 Danaher Corporation
    • 10.10.1 Business overview
    • 10.10.2 Financial data
    • 10.10.3 Product landscape
    • 10.10.4 Strategic outlook
    • 10.10.5 SWOT analysis
  • 10.11 PBS Biotech
    • 10.11.1 Business overview
    • 10.11.2 Financial data
    • 10.11.3 Product landscape
    • 10.11.4 Strategic outlook
    • 10.11.5 SWOT analysis
  • 10.12 Pierre Guerin Sas (Engie)
    • 10.12.1 Business overview
    • 10.12.2 Financial data
    • 10.12.3 Product landscape
    • 10.12.4 Strategic outlook
    • 10.12.5 SWOT analysis
  • 10.13 Sartorius Stedim Biotech Group
    • 10.13.1 Business overview
    • 10.13.2 Financial data
    • 10.13.3 Product landscape
    • 10.13.4 Strategic outlook
    • 10.13.5 SWOT analysis
  • 10.14 Shanghai Bailun Biotechnology Co. Ltd.,
    • 10.14.1 Business overview
    • 10.14.2 Financial data
    • 10.14.3 Product landscape
    • 10.14.4 Strategic outlook
    • 10.14.5 SWOT analysis
  • 10.15 Solaris Biotech Solutions
    • 10.15.1 Business overview
    • 10.15.2 Financial data
    • 10.15.3 Product landscape
    • 10.15.4 Strategic outlook
    • 10.15.5 SWOT analysis
  • 10.16 Thermo Fisher Scientific
    • 10.16.1 Business overview
    • 10.16.2 Financial data
    • 10.16.3 Product landscape
    • 10.16.4 Strategic outlook
    • 10.16.5 SWOT analysis

Data Tables

  • TABLE 1. Global bioreactors market, 2017 - 2021 (USD Million)
  • TABLE 2. Global bioreactors market, 2022 - 2030 (USD Million)
  • TABLE 3. Global bioreactors market, by product type, 2017 - 2021 (USD Million)
  • TABLE 4. Global bioreactors market, by product type, 2022 - 2030 (USD Million)
  • TABLE 5. Global bioreactors market, by cell, 2017 - 2021 (USD Million)
  • TABLE 6. Global bioreactors market, by cell, 2022 - 2030 (USD Million)
  • TABLE 7. Global bioreactors market, by molecule, 2017 - 2021 (USD Million)
  • TABLE 8. Global bioreactors market, by molecule, 2022 - 2030 (USD Million)
  • TABLE 9. Global bioreactors market, by usage, 2017 - 2021 (USD Million)
  • TABLE 10. Global bioreactors market, by usage, 2022 - 2030 (USD Million)
  • TABLE 11. Global bioreactors market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 12. Global bioreactors market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 13. Global bioreactors market, by region, 2017 - 2021 (USD Million)
  • TABLE 14. Global bioreactors market, by region, 2022 - 2030 (USD Million)
  • TABLE 15. Industry impact forces
  • TABLE 16. Single-use market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Single-use market size, by region, 2022 - 2030 (USD Million)
  • TABLE 18. Reusable market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Reusable market size, by region, 2022 - 2030 (USD Million)
  • TABLE 20. Mammalian cells size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Mammalian cells market size, by region, 2022 - 2030 (USD Million)
  • TABLE 22. Bacterial cells market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. Bacterial cells market size, by region, 2022 - 2030 (USD Million)
  • TABLE 24. Yeast cells market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Yeast cells market size, by region, 2022 - 2030 (USD Million)
  • TABLE 26. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 28. Monoclonal antibodies size, by region, 2017 - 2021 (USD Million)
  • TABLE 29. Monoclonal antibodies market size, by region, 2022 - 2030 (USD Million)
  • TABLE 30. Vaccines market size, by region, 2017 - 2021 (USD Million)
  • TABLE 31. Vaccines market size, by region, 2022 - 2030 (USD Million)
  • TABLE 32. Recombinant protein market size, by region, 2017 - 2021 (USD Million)
  • TABLE 33. Recombinant protein market size, by region, 2022 - 2030 (USD Million)
  • TABLE 34. Stem cells market size, by region, 2017 - 2021 (USD Million)
  • TABLE 35. Stem cells market size, by region, 2022 - 2030 (USD Million)
  • TABLE 36. Gene therapy market size, by region, 2017 - 2021 (USD Million)
  • TABLE 37. Gene therapy market size, by region, 2022 - 2030 (USD Million)
  • TABLE 38. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 39. Others market size, by region, 2022 - 2030 (USD Million)
  • TABLE 40. Developmental, pre-clinical and clinical size, by region, 2017 - 2021 (USD Million)
  • TABLE 41. Developmental, pre-clinical and clinical market size, by region, 2022 - 2030 (USD Mn)
  • TABLE 42. Commercial production market size, by region, 2017 - 2021 (USD Million)
  • TABLE 43. Commercial production market size, by region, 2022 - 2030 (USD Million)
  • TABLE 44. R&D organizations market size, by region, 2017 - 2021 (USD Million)
  • TABLE 45. R&D organizations market size, by region, 2022 - 2030 (USD Million)
  • TABLE 46. Biopharma manufacturers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 47. Biopharma manufacturers market size, by region, 2022 - 2030 (USD Million)
  • TABLE 48. CMOs market size, by region, 2017 - 2021 (USD Million)
  • TABLE 49. CMOs market size, by region, 2022 - 2030 (USD Million)
  • TABLE 50. North America bioreactors market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 51. North America bioreactors market size, by country, 2022 - 2030 (USD Mn)
  • TABLE 52. North America bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 53. North America bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 54. North America bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 55. North America bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 56. North America bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 57. North America bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 58. North America bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 59. North America bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 60. North America bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 61. North America bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 62. U.S. bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 63. U.S. bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 64. U.S. bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 65. U.S. bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 66. U.S. bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 67. U.S. bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 68. U.S. bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 69. U.S. bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 70. U.S. bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 71. U.S. bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 72. Canada bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 73. Canada bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 74. Canada bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 75. Canada bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 76. Canada bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 77. Canada bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 78. Canada bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 79. Canada bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 80. Canada bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 81. Canada bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 82. Europe bioreactors market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 83. Europe bioreactors market size, by country, 2022 - 2030 (USD Mn)
  • TABLE 84. Europe bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 85. Europe bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 86. Europe bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 87. Europe bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 88. Europe bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 89. Europe bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 90. Europe bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 91. Europe bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 92. Europe bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 93. Europe bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 94. Germany bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 95. Germany bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 96. Germany bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 97. Germany bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 98. Germany bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 99. Germany bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 100. Germany bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 101. Germany bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 102. Germany bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 103. Germany bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 104. UK bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 105. UK bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 106. UK bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 107. UK bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 108. UK bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 109. UK bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 110. UK bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 111. UK bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 112. UK bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 113. UK bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 114. France bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 115. France bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 116. France bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 117. France bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 118. France bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 119. France bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 120. France bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 121. France bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 122. France bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 123. France bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 124. Italy bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 125. Italy bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 126. Italy bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 127. Italy bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 128. Italy bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 129. Italy bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 130. Italy bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 131. Italy bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 132. Italy bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 133. Italy bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 134. Spain bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 135. Spain bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 136. Spain bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 137. Spain bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 138. Spain bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 139. Spain bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 140. Spain bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 141. Spain bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 142. Spain bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 143. Spain bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 144. Netherlands bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 145. Netherlands bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 146. Netherlands bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 147. Netherlands bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 148. Netherlands bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 149. Netherlands bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 150. Netherlands bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 151. Netherlands bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 152. Netherlands bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 153. Netherlands bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 154. Denmark bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 155. Denmark bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 156. Denmark bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 157. Denmark bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 158. Denmark bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 159. Denmark bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 160. Denmark bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 161. Denmark bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 162. Denmark bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 163. Denmark bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 164. Asia Pacific bioreactors market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 165. Asia Pacific bioreactors market size, by country, 2022 - 2030 (USD Mn)
  • TABLE 166. Asia Pacific bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 167. Asia Pacific bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 168. Asia Pacific bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 169. Asia Pacific bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 170. Asia Pacific bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 171. Asia Pacific bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 172. Asia Pacific bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 173. Asia Pacific bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 174. Asia Pacific bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 175. Asia Pacific bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 176. Japan bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 177. Japan bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 178. Japan bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 179. Japan bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 180. Japan bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 181. Japan bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 182. Japan bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 183. Japan bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 184. Japan bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 185. Japan bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 186. China bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 187. China bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 188. China bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 189. China bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 190. China bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 191. China bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 192. China bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 193. China bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 194. China bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 195. China bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 196. India bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 197. India bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 198. India bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 199. India bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 200. India bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 201. India bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 202. India bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 203. India bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 204. India bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 205. India bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 206. Australia bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 207. Australia bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 208. Australia bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 209. Australia bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 210. Australia bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 211. Australia bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 212. Australia bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 213. Australia bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 214. Australia bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 215. Australia bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 216. South Korea bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 217. South Korea bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 218. South Korea bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 219. South Korea bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 220. South Korea bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 221. South Korea bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 222. South Korea bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 223. South Korea bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 224. South Korea bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 225. South Korea bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 226. Singapore bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 227. Singapore bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 228. Singapore bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 229. Singapore bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 230. Singapore bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 231. Singapore bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 232. Singapore bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 233. Singapore bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 234. Singapore bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 235. Singapore bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 236. Latin America bioreactors market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 237. Latin America bioreactors market size, by country, 2022 - 2030 (USD Mn)
  • TABLE 238. Latin America bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 239. Latin America bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 240. Latin America bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 241. Latin America bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 242. Latin America bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 243. Latin America bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 244. Latin America bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 245. Latin America bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 246. Latin America bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 247. Latin America bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 248. Brazil bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 249. Brazil bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 250. Brazil bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 251. Brazil bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 252. Brazil bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 253. Brazil bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 254. Brazil bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 255. Brazil bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 256. Brazil bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 257. Brazil bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 258. Mexico bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 259. Mexico bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 260. Mexico bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 261. Mexico bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 262. Mexico bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 263. Mexico bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 264. Mexico bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 265. Mexico bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 266. Mexico bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 267. Mexico bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 268. Middle East & Africa bioreactors market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 269. Middle East & Africa bioreactors market size, by country, 2022 - 2030 (USD Mn)
  • TABLE 270. Middle East & Africa bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 271. Middle East & Africa bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 272. Middle East & Africa bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 273. Middle East & Africa bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 274. Middle East & Africa bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 275. Middle East & Africa bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 276. Middle East & Africa bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 277. Middle East & Africa bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 278. Middle East & Africa bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 279. Middle East & Africa bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 280. South Africa bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 281. South Africa bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 282. South Africa bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 283. South Africa bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 284. South Africa bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 285. South Africa bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 286. South Africa bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 287. South Africa bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 288. South Africa bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 289. South Africa bioreactors market size, by end-use, 2022 - 2030 (USD Mn)
  • TABLE 290. UAE bioreactors market size, by product type, 2017 - 2021 (USD Mn)
  • TABLE 291. UAE bioreactors market size, by product type, 2022 - 2030 (USD Mn)
  • TABLE 292. UAE bioreactors market size, by cell, 2017 - 2021 (USD Mn)
  • TABLE 293. UAE bioreactors market size, by cell, 2022 - 2030 (USD Mn)
  • TABLE 294. UAE bioreactors market size, by molecule, 2017 - 2021 (USD Mn)
  • TABLE 295. UAE bioreactors market size, by molecule, 2022 - 2030 (USD Mn)
  • TABLE 296. UAE bioreactors market size, by usage, 2017 - 2021 (USD Mn)
  • TABLE 297. UAE bioreactors market size, by usage, 2022 - 2030 (USD Mn)
  • TABLE 298. UAE bioreactors market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 299. UAE bioreactors market size, by end-use, 2022 - 2030 (USD Mn)

Charts & Figures

  • FIG. 1 Market estimation approach
  • FIG. 2 Data validation
  • FIG. 3 Bioreactors industry 360 degree synopsis, 2017-2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global bioreactors market, 2017-2030 (USD Million)
  • FIG. 6 Growth potential analysis, by product type
  • FIG. 7 Growth potential analysis, by cell
  • FIG. 8 Growth potential analysis, by molecule
  • FIG. 9 Growth potential analysis, by usage
  • FIG. 10 Growth potential analysis, by end-use
  • FIG. 11 Porter's analysis
  • FIG. 12 Company matrix analysis, 2021
  • FIG. 13 PESTEL analysis
  • FIG. 14 Key segment trends, by product type
  • FIG. 15 Key segment trends, by cell
  • FIG. 16 Key segment trends, by molecule
  • FIG. 17 Key segment trends, by usage
  • FIG. 18 Key segment trends, by end-use
  • FIG. 19 Key regional trends
  • FIG. 20 Competitive dashboard, 2021